Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4833 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
1998-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2002-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5814f4c31a883ed95fac8979ab7a375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89f04fe05888edb480ce823f04d7c93d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bd413f5bef6d6ce4c048e99ac5abf39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16c30f7c1839bc9fe11bd73e31cdb233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5603f05d1d3358f321bddf9d97b2470f |
publicationDate |
2002-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6337090-B1 |
titleOfInvention |
Orally administrable solid ribavirin dosage forms and process for making them |
abstract |
An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin and a process for making such solid dosage forms are disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008131398-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7538094-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006083785-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003104050-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005019406-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010203127-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7723310-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005075297-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009012015-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6720000-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011029868-A1 |
priorityDate |
1997-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |